RxDoctor Payments Data

Mary Hilton, PA

Medical · Springdale, ARNPI 1134474661

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.6% of the total across 214 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations.

$4,120in general payments, 2019–2025

Across 214 payments — averaging $19.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$807
  • Lilly USA, LLC$719
  • Johnson & Johnson$573
  • Sanofi$432
  • Pfizer$317
  • UCB, Inc.$276
  • plus $996 from 12 others

What the payments were for

  • Food & beverage$3,77592%
  • Education$3448%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,120 in reported general payments places this provider in the 80th percentile of 133 medical providers in Arkansas.

See all medical providers in Arkansas

Medicare billing

Part B allowed, 2024
$341,250
Medicare patients
507
Services billed
3,980

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab24$92,487
Cosentyx Sensoready (2 Pens)Secukinumab11$80,191
Taltz AutoinjectorIxekizumab11$77,532
Ivermectin11$3,282
Clobetasol Propionate68$2,672
Tretinoin19$1,530
Metronidazole21$1,342
Doxycycline Hyclate37$833
Ketoconazole60$711
Mupirocin51$413
Triamcinolone Acetonide64$390
Finasteride28$322
Hydrocortisone70$284
Mometasone Furoate15$259
ValacyclovirValacyclovir Hcl15$229

Paid to pharmacies, not to this prescriber.

Other medical in Springdale

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →